Content about Maryland

March 21, 2012

Bath and beauty brand Calgon, which is managed by Ilex Consumer Products Group, has announced the return of its Turquoise Seas fragrance after more than five years off the shelf.

BALTIMORE, Md. — Bath and beauty brand Calgon, which is managed by Ilex Consumer Products Group, has announced the return of its Turquoise Seas fragrance after more than five years off the shelf.

March 20, 2012

M-Edge has unveiled its latest collection of tablet, smartphone and e-reader accessories in time for spring.

ODENTON, Md. — M-Edge has unveiled its latest collection of tablet, smartphone and e-reader accessories in time for spring.

March 19, 2012

The Food and Drug Administration has approved the first generic version of a drug for treating and preventing osteoporosis in women after menopause, the agency said Monday.

SILVER SPRING, Md. — The Food and Drug Administration has approved the first generic version of a drug for treating and preventing osteoporosis in women after menopause, the agency said Monday.

The FDA announced the approval of ibandronate tablets in the 150-mg strength made by Apotex, Orchid Healthcare and Mylan Pharmaceuticals. Genentech makes the branded version of the drug.

March 14, 2012

The Food and Drug Administration has approved the first generic version of an antidepressant made by Forest Labs, the agency said Wednesday.

SILVER SPRINGS, Md. — The Food and Drug Administration has approved the first generic version of an antidepressant made by Forest Labs, the agency said Wednesday.

The FDA announced the approval of a generic version of Lexapro (escitalopram) made by Teva Pharmaceutical Industries in the 5-mg, 10-mg and 20-mg strengths. The drug is used to treat depression and generalized anxiety disorder in adults.

March 8, 2012

The Food and Drug Administration is looking at the possibility of selling certain prescription drugs over the counter under specific circumstances, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration is looking at the possibility of selling certain prescription drugs over the counter under specific circumstances, the agency said.

March 6, 2012

Annapolis, Md.-based St. Joseph Consumer Health last week unveiled a new St. Joseph-branded line of cough cold products formulated for patients with high blood pressure at the ECRM Cough & Cold and Allergy EPPS.

LAS VEGAS — Annapolis, Md.-based St. Joseph Consumer Health last week unveiled a new St. Joseph-branded line of cough-cold products formulated for patients with high blood pressure at the ECRM Cough & Cold and Allergy EPPS.

The products all feature "decongestant-free" on the package underneath the St. Joseph brand, long known for its 81-mg daily aspirin regimen. The lineup includes a multi-symptom day/night caplet formulation, two formulations targeting cold and flu symptoms and a cough tablet SKU.

March 1, 2012

The Food and Drug Administration has approved what it called the first flu vaccine to prevent four strains of the influenza virus.

SILVER SPRING, Md. — The Food and Drug Administration has approved what it called the first flu vaccine to prevent four strains of the influenza virus.

March 1, 2012

The Food and Drug Administration has approved two new drugs for pancreatic disorders, the agency said Thursday.

SILVER SPRING, Md. — The Food and Drug Administration has approved two new drugs for pancreatic disorders, the agency said Thursday.

The FDA announced the approval of Aptalis Pharma's Ultresa and Viokase, both generically known as pancrelipase. Ultresa is a delayed-release capsule for children and adults with cystic fibrosis, which affects the lungs and other organs, while Viokase is meant for use with a proton-pump inhibitor in adults who can't digest food because of pancreatitis or surgical removal of the pancreas.

February 28, 2012

The Food and Drug Administration on Tuesday announced it will hold a public hearing on March 22 and 23 to discuss how technology can expand which drug products can be switched from prescription to over-the-counter status.

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday announced it will hold a public hearing on March 22 and 23 to discuss how technology can expand which drug products can be switched from prescription to over-the-counter status.

February 28, 2012

Drugs widely used to treat cholesterol may cause increases in blood sugar and other symptoms, the Food and Drug Administration said Tuesday.

SILVER SPRING, Md. — Drugs widely used to treat cholesterol may cause increases in blood sugar and other symptoms, the Food and Drug Administration said Tuesday.

February 23, 2012

The Food and Drug Administration has approved a drug for a rare disorder that previously had no approved medical therapies, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug for a rare disorder that previously had no approved medical therapies, the agency said.

The FDA announced the approval of Menlo Park, Calif.-based Corcept Therapeutics' Korlym (mifepristone) for endogenous Cushing's syndrome, a disorder that results from overproduction of cortisol, a steroid hormone that increases blood-sugar levels.

February 21, 2012

An executive order from the Obama administration has spurred the Food and Drug Administration to address shortages of two cancer drugs and issue draft guidance for the industry to help prevent future shortages, the agency said Tuesday.

SILVER SPRING, Md. — An executive order from the Obama administration has spurred the Food and Drug Administration to address shortages of two cancer drugs and issue draft guidance for the industry to help prevent future shortages, the agency said Tuesday.

February 21, 2012

LimbO Products on Tuesday announced the launch of its new website, Limboproducts.com.

CHESTERTOWN, Md. — LimbO Products on Tuesday announced the launch of its new website, Limboproducts.com. The site was developed to support the recent introduction of LimbO Waterproof Protectors in the United States.

Manufactured by Thesis Technology Products in the United Kingdom, LimbO Waterproof Protectors enable children and adults to safely take a shower or bath with a cast or a bandage.

February 16, 2012

One of the supermarket chains operated by Netherlands-based Royal Ahold has installed rooftop solar panels at two of its stores.

LANCASTER, Pa. — One of the supermarket chains operated by Netherlands-based Royal Ahold has installed rooftop solar panels at two of its stores.

Carlisle, Pa.-based Giant Food Stores — also known as Giant-Carlisle to distinguish it from Landover, Md.-based Giant Food, also owned by Ahold — said it had installed solar photovoltaic systems at stores in Lancaster and Pottstown, Pa.

February 16, 2012

Marley Coffee has inked a distribution agreement that will expands its line's availability on the East Coast, as well as in Hawaii.

LOS ANGELES — Marley Coffee has inked a distribution agreement that will expands its line's availability on the East Coast, as well as in Hawaii.

February 15, 2012

Fake versions of a cancer drug made by Roche's U.S. unit have entered the United States, the Food and Drug Administration warned Wednesday.

SILVER SPRING, Md. — Fake versions of a cancer drug made by Roche's U.S. unit have entered the United States, the Food and Drug Administration warned Wednesday.

The FDA advised healthcare professionals and patients that a counterfeit version of Genentech's Avastin (bevacizumab) had been distributed in the United States. The agency said the counterfeit versions carried Roche's logo instead of Genentech's and displayed batch numbers starting with B6010, B6011 or B86017.

February 14, 2012

A provider of mobile health solutions has introduced a free application that synchronizes with a wireless blood-glucose meter.

BETHESDA, Md. — A provider of mobile health solutions has introduced a free application that synchronizes with a wireless blood-glucose meter.

The MyTelcare Diabetes Pal, now available via the Apple App Store, allows patients and caregivers to use their iPhone, iPod Touch and/or iPad to visualize every glucose reading sent by the Telcare BGM (blood-glucose meter) while tracking medication, nutrition, activities and notes. What's more, the app also enables patients who don’t have the Telcare BGM to manually enter their blood-glucose data and track it over time.

February 14, 2012

The National Consumers League, the National Association of Chain Drug Stores Foundation and the American Association of Colleges of Pharmacy have recognized five pharmacy schools for their public education efforts to help patients adhere to their medication routines.

WASHINGTON — The National Consumers League, the National Association of Chain Drug Stores Foundation and the American Association of Colleges of Pharmacy have recognized five pharmacy schools for their public education efforts to help patients adhere to their medication routines.

February 9, 2012

The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

SILVER SPRING, Md. — The Food and Drug Administration on Wednesday issued a public warning that the use of proton-pump inhibitors or H2 blockers may be associated with an increased risk of Clostridium difficile–associated diarrhea, or CDAD.

Patients should immediately contact their healthcare professional and seek care if they take PPIs and develop diarrhea that does not improve, the agency stated.

February 9, 2012

The Food and Drug Administration reached a major milestone on the path to a regulatory regime for follow-on biologics on Thursday with the release of draft guidance on biosimilar product development.

SILVER SPRING, Md. — The Food and Drug Administration reached a major milestone on the path to a regulatory regime for follow-on biologics on Thursday with the release of draft guidance on biosimilar product development.

February 6, 2012

Supermarket chain Giant Food has acquired two supermarkets in the Baltimore area from another company, Giant said.

LANDOVER, Md. — Supermarket chain Giant Food has acquired two supermarkets in the Baltimore area from another company, Giant said.

Giant, also known as Giant-Landover to distinguish itself from Giant Food Stores of Carlisle, Pa. — both are owned by Netherlands-based Royal Ahold — said it would buy two Fresh & Green's stores from Mrs. Green's Management. The stores are in Baltimore and Parkville, Md.

Both stores will subsequently be closed for remodeling, and the Baltimore store will replace a Giant store at a nearby shopping center.

February 6, 2012

In honor of American Heart Month, Sam's Club announced it will be hosting free heart health screenings on Feb. 11 at all locations with a pharmacy.

BENTONVILLE, Ark. — In honor of American Heart Month, Sam's Club announced it will be hosting free heart health screenings on Feb. 11 at all locations with a pharmacy.

From 11 a.m. to 3 p.m., members and guests can receive total cholesterol, HDL, glucose, body mass index and blood-pressure tests for free. During the screenings, Sam's Club pharmacies also will offer free samples of related items, the company said.

February 1, 2012

The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.

The FDA approved Novartis' Gleevec (imatinib) for adults who have had gastrointestinal stromal tumors, or GIST, removed. The drug was specifically approved for people whose tumors are known as CD117-positive, which includes 95% of all GIST tumors.

The drug was originally approved in 2001 for a type of leukemia.

January 31, 2012

The Food and Drug Administration has approved a drug made by Vertex Pharmaceuticals for treating a rare form of cystic fibrosis, the agency said Tuesday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a drug made by Vertex Pharmaceuticals for treating a rare form of cystic fibrosis, the agency said Tuesday.

The FDA announced the approval of Kalydeco (ivacaftor) for treating patients ages 6 years and older with CF who have a mutation called G551D in the cystic fibrosis transmembrane regulator gene.

January 30, 2012

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating the most common type of skin cancer, the agency said Monday.

The FDA announced the approval of Genentech's Erivedge (vismodegib) for adults with basal cell carcinoma who are not surgery or radiation therapy candidates and whose disease is locally advanced or has spread to other parts of the body.